Abcam and the other 17 members of the partnership today launched the IHI project, LIGAND-AI, to advance AI-driven drug ...

UCL joins global €60m AI-driven drug discovery initiative to generate open datasets and accelerate new medicines using AI models ...

A new global public-private partnership using artificial intelligence (AI) to accelerate drug discovery is launching with UCL as one of the lead ...

The "Optical Genome Mapping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been ...

Oregon State University researchers have painted a clearer picture of the coastal marten, a secretive, ferret-sized forest carnivore renowned for its cuteness but nearly driven to extinction by human ...

According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...

High-resolution analytical platforms, proteomics-driven workflows, and expanding CRO outsourcing reshape strategic priorities ...

Machine learning models are designed to analyze large, heterogeneous datasets and identify complex relationships without ...

Saliva is an easily accessible source of high molecular weight DNA for Oxford Nanopore long-read sequencing applications.

A research team reports that advances in protein design—especially when combined with artificial intelligence—are rapidly ...

Artificial intelligence (AI) is transforming the life sciences industry, with potentially its most significant impact on drug ...

Explore the connection between neurodegeneration and cellular senescence in understanding brain structure and ageing.